Rbf1 degron dysfunction enhances cellular DNA replication

Abstract

The E2F family of transcription factors contributes to oncogenesis through activation of multiple genes involved in cellular proliferation, a process that is opposed by the Retinoblastoma tumor suppressor protein (RB). RB also increases E2F1 stability by inhibiting its proteasome-mediated degradation, but the consequences of this post-translational regulation of E2F1 remain unknown. To better understand the mechanism of E2F stabilization and its physiological relevance, we examined the streamlined Rbf1-dE2F1 network in Drosophila. During embryonic development, Rbf1 is insulated from ubiquitin-mediated turnover by the COP9 signalosome, a multi-protein complex that modulates E3 ubiquitin ligase activity. Here, we report that the COP9 signalosome also protects the Cullin4-E3 ligase that is responsible for dE2F1 proteasome-mediated destruction. This dual role of the COP9 signalosome may serve to buffer E2F levels, enhancing its turnover via Cul4 protection and its stabilization through protection of Rbf1. We further show that Rbf1-mediated stabilization of dE2F1 and repression of dE2F1 cell cycle-target genes are distinct properties. Removal of an evolutionarily conserved Rbf1 C terminal degron disabled Rbf1 repression without affecting dE2F1 stabilization. This mutant form of Rbf1 also enhanced G₁-to-S phase progression when expressed in Rbf1-containing S2 embryonic cells, suggesting that such mutations may generate gain-of-function properties relevant to cellular transformation. Consistent with this idea, several studies have identified mutations in the homologous C terminal domains of RB and p130 in human cancer.

Keywords: :

• retinoblastoma
• tumor suppressor
• E2F1
• repression
• proteasome
• ubiquitin
• degron

Acknowledgments

We thank Nick Dyson for sharing the PCNA-luciferase reporter gene, Maxim Frolov for the pIE-E2F1 construct, Robert Duronio for the anti-Cul4 antibody, Maki Asano for the anti-E2F1 antibody, Louis King for expert assistance with flow cytometry and Satyaki Sengupta for his thoughtful comments. This work was supported by the MSU Gene Expression in Development and Disease Group, and a grant from the NIH to D.N.A and R.W.H (1R01GM079098).